HuagongsheHuagongshe Chemistry Print Report · For research reference only
(1-methyl-1H-imidazol-4-yl)methanamine → N-((1-Methyl-1H-imidazol-4-yl)methyl)-7-(4-(2-(pyridin-2-yl)ethyl)piperazin-1-yl)benzofuran-2-carboxamide
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | (1-methyl-1H-imidazol-4-yl)methanamine | HCID 2795114 | — |
| Reactant | Lithium 7-(4-(2-(pyridin-2-yl)ethyl)piperazin-1-yl)benzofuran-2-carboxylate | HCID 68787401 | — |
| Product | N-((1-Methyl-1H-imidazol-4-yl)methyl)-7-(4-(2-(pyridin-2-yl)ethyl)piperazin-1-yl)benzofuran-2-carboxamide | HCID 59636775 | — |
Reaction Steps
The compound was prepared according to the procedure disclosed in Example 1 starting from lithium 7-(4-(2-(pyridin-2-yl)ethyl)piperazin-1-yl)benzofuran-2-carboxylate (70 mg, 0.18 mmol) and (1-methyl-1H-imidazol-4-yl)methylamine (24 mg, 0.22 mmol). Yield: 42 mg (48%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08859534B2 |
| Source dataset | uspto-grants-2014_10 |
| ORD ID | ord-cf7c65bafb4a4c0b9b3fc375a542c6d8 |
| Source note | uspto-grants-2014_10 |